Mariusz A. Goscinski
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.
Journal: Oncotarget
Published: November 07, 2025
Short-term results after robot-assisted surgery for primary rectal cancers requiring beyond total mesorectal excision in multiple compartments.
Journal: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
Published: October 03, 2023
First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study).
Journal: Frontiers in medicine
Published: October 14, 2022
Partial splenectomy after preoperative embolization in a patient with metastatic melanoma - A case report.
Journal: International journal of surgery case reports
Published: January 15, 2022
Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site.
Journal: Journal of plastic surgery and hand surgery
Published: December 08, 2021
HIPEC in Complementary Treatment to Cytoreductive Procedures: An Unexplained Issue After the PRODIGE 7 Trial.
Journal: Annals of surgical oncology
Published: September 22, 2021
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients.
Journal: British journal of cancer
Published: April 28, 2021
Correction: Potent and specific MTH1 inhibitors targeting gastric cancer.
Journal: Cell death & disease
Published: October 17, 2020
Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer.
Journal: Frontiers in oncology
Published: September 15, 2019
High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients.
Journal: Pathology, research and practice
Published: July 20, 2019
High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer.
Journal: OncoTargets and therapy
Published: June 09, 2018
Last Updated: 09/26/2026